J. H. Machiels

Prognosis of Severely Hypoxemic Patients Receiving Long-term Oxygen Therapy

Pierre Dubois, Jacques Jamart, J. H. Machiels et al. · CHEST Journal · 1994 · 103 citations

Health Professions, Internal Medicine, Respiratory Therapy +12

Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC).

Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu et al. · Journal of Clinical Oncology · 2010 · 94 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor

Thomas E. Hutson, Ian D. Davis, J. H. Machiels et al. · Journal of Clinical Oncology · 2008 · 85 citations

Medicine, Oncology, Pharmacology +17

Survival benefit from first docetaxel treatment for cabazitaxel plus prednisone compared with mitoxantrone plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in the TROPIC trial.

Oliver Sartor, Stéphane Oudard, Mustafa Özgüroğlu et al. · Journal of Clinical Oncology · 2011 · 19 citations

Medicine, Oncology, Pharmacology +15

Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: A dose escalation study of carboplatin

Yves Humblet, P. Weynants, André Bosly et al. · Medical Oncology and Tumor Pharmacotherapy · 1989 · 15 citations

Medicine, Oncology, Pharmacology +14